The association of epigenetic age acceleration and multimorbidity at age 90 in the Women's Health Initiative.

Purva JainAlexandra BinderBrian ChenHumberto ParadaLinda C GalloJohn AlcarazSteve HorvathParveen BhattiEric A WhitselKristina JordahlAndrea A BaccarelliLifang HouJames D StewartYun LiMichael J LaMonteJoAnn E MansonAndrea Z LaCroix

Published in: The journals of gerontology. Series A, Biological sciences and medical sciences (2022)

AgeAccelPheno and AgeAccelHannum may predict multimorbidity count and score at age 90 in older women and, thus, may be useful as a biomarker predictor of multimorbidity burden in the last decades of life.

Keyphrases

healthcare
public health
dna methylation
gene expression
quality improvement
pregnant women
metabolic syndrome
risk assessment
pregnancy outcomes
climate change
social media
insulin resistance